All In MedTech

Device Trial Radar · NCT01253356

ACTIONS - Aortic Counterpulsation to Improve Outcomes in Noncardiac Surgery

A Multicenter, Randomized, Controlled Pilot Study of Intra-Aortic Balloon Counterpulsation to Prevent Perioperative Cardiac Events in High-Risk Cardiac Patients Undergoing Noncardiac Surgery

Last checked: Nov 19, 2026Latest source record: Jan 6, 2012 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

1

Actual

Start

Jan 2011

Primary completion

Jan 2012

Study completion Feb 2012

Sponsor

Lead sponsor
Datascope Corp.Not on our public-company list
Sponsor type
Industry
First posted
Dec 3, 2010

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The use of the IABP, in addition to standard care, in high-risk cardiac patients undergoing major noncardiac surgery is feasible and may result in improved perioperative outcomes at 30 days compared with standard care alone, while maintaining acceptable safety with respect to vascular accesss-related complications.

Conditions

  • Patients With History of Ischemic Heart Disease With LV Dysfunction Undergoing Noncardiac Surgery

Interventions

  • IABPDevice

    Insertion of intra-aortic balloon \< or = 3 hours before noncardiac surgery and maintained \> or = 12-24 hours after surgery

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. SafetyTime frame: 30 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Genesis Medical Center

    Davenport, Iowa

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.